RSS Feeds
Search

Out-licensing

Up-to-date access to technology licensing opportunities worldwide.

Licensing opportunities

Displaying 1..1 of 1 - per page
Order by
Cripto-1 Represents a Biomarker for Chronic Inflammatory Diseases
Cripto-1 expression increases the expression of TNF-alpha in CD4+ T cells in tissues affected by chronic inflammatory disease. More
Displaying 1..1 of 1 - per page
Order by

Related Reports

Market Research Reports provided by reports.iptechex.com
Ulcerative Colitis Therapy Area Pipeline Report
Nov 2010 - 321 pages - $1,495
Gastrointestinal Disorders Therapy Area Pipeline Report
Nov 2010 - 933 pages - $1,495
Gastrointestinal (Stomach) Cancer Therapy Area Pipeline Report
Nov 2010 - 324 pages - $1,495
Epidemiology: Inflammatory Bowel Disease - Stable incidence but high prevalence due to early diagnosis and improved survival
Mar 2011 - 32 pages - $5,700
Deals and alliances in gastrointestinal diseases
Jun 2006 - 278 pages - $2,495
Diagnostics Partnering Terms and Agreements
Feb 2012 - 1350 pages - $2,695
Ulcerative Colitis Therapeutics - Pipeline Assessment and Market Forecasts to 2017
Dec 2010 - 44 pages - $2,000
Hokkaido Gastrointestinal Cancer Study Group – Developmental Therapeutics Review – Q4 2010
Dec 2010 - 30 pages - $500
Spanish Cooperative Group for Gastrointestinal Tumour Therapy – Developmental Therapeutics Review – Q4 2010
Dec 2010 - 41 pages - $500
Spanish Cooperative Group for Gastrointestinal Tumour Therapy – Developmental Therapeutics Review – Q1 2011
Mar 2011 - 41 pages - $500
More Related Market Research Reports >>>

Your selection

Industry sector
Diagnostic del
Therapeutic target
Gastrointestinal del
Colitis del
Development phase
Early Stage del

Browse By

Industry sector
Antibody-based diagnostics
Biomarker-based diagnostics
CAT
Genetic diagnostics
Imaging
MRI
Nuclear medicine
Other
Self-test systems
Supplies
Test systems
Ultrasound
X-ray

Clients in focus...

Get the Flash Player to see this rotator.

© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us